| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $256.4M | +0.8% | +6.6% |
| Cost of Revenue | $87.6M | +0.1% | +3.3% |
| R&D Expense | $66.6M | -3.5% | +7.1% |
| SG&A Expense | $27.9M | +3.0% | +8.5% |
| Operating Income | $37.0M | +15.6% | +11.5% |
| Pre-tax Income | $47.5M | +20.7% | +10.0% |
| Income Tax | $15.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.07B | +4.1% | -8.9% |
| Accounts Receivable | $111.0M | -9.2% | -8.3% |
| Inventory | $92.3M | +2.5% | +23.0% |
| Current Assets | $1.35B | +4.1% | -4.8% |
| Total Assets | $2.12B | +1.2% | +7.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $117.4M | — | — |
| Capital Expenditures | $15.4M | — | — |
| Investing Cash Flow | -$250.0M | — | — |
| Financing Cash Flow | -$21.5M | — | — |
| Free Cash Flow | $102.0M | — | — |
| +178.5% |
| +126.3% |
| Net Income | $35.1M | +2.6% | -4.3% |
| EPS (Basic) | $0.71 | +2.9% | -4.1% |
| EPS (Diluted) | $0.65 | +3.2% | -3.0% |
| $654.0M |
| -1.2% |
| +301.0% |
| Total Liabilities | $1.24B | -0.5% | +0.0% |
| Stockholders' Equity | $827.2M | +3.7% | +19.8% |